Hot investment opportunities focus on Medical Device Monitors and Sensors

There is significant interest from #venturecapital #pharma and#healthinsurance companies in personal health monitors and sensors.  Google, Apple, Samsung, Microsoft and others are changing the #MedicalDevice industry along with hundreds of startups.  Smart $$$ is moving to medical devices that monitor patient health.  This will build patient accountability into the system that does not exist under todays health delivery system in any significant manner.  The devices must clear FDA or other regulatory agency for efficacy and safety.  Of course positive outcomes is an expectation on the monitoring and aggregation of this data.

http://www.inc.com/christina-desmarais/3-hot-opportunities-in-health-for-tech-startups.html?cid=sf01001

One of the first Clinical Trials information system to seamlessly communicate test result information from Investigators to Reference Laboratories to Pharmaceutical Companies.  This Product along with Protocol Master was utilized in Pharmaceutical Companies such as Roche, Johnson & Johnson (Janssen Division) and Otsuka America.  The Protocol Master product was used as a front end to an early Oracle database and incorporated coding for adverse events, WHO codes, ICD9, and CPT coding.  The system utilized the ASTM 1238 protocol for the clinical transactions.

The utility of the system was part of a demonstration at the DIA (Drug Information Association) meeting in 1992 by Otsuka America Pharmaceuticals.